The DOI matches its Crossref record; 45 of the 47 references it cites were found in a registry or an index.
The epidemiology of antidepressant use in South Korea: does short-term antidepressant use affect the relapse and recurrence of depressive episodes
Open accessAbstract
BACKGROUND: The duration of antidepressant use affects the treatment of depression. Using the National Health Insurance database, which covers almost the entire national population, we verified the factors associated with the inadequate short-term use of initially prescribed antidepressants and their effects on the relapse and recurrence of depressive episodes. METHODS: There were 752,190 patients included who had been newly prescribed antidepressants in 2012 with the diagnosis of depressive disorder. They were followed-up until December 31, 2015. They were classified as short-term and long-term antidepressant users depending on whether they used a specific initial antidepressant for at least four weeks. Sociodemographic, clinical, and medical utilization factors affecting the duration of antidepressant use were investigated. We also identified whether the duration of antidepressant use affected the risk of relapse and recurrence, which was defined by the restarting of antidepressants. RESULTS: Initial antidepressants were taken for less than 28 days by 458,057 (60.84%) patients. Tricyclic antidepressants were used as the initial antidepressant more frequently than selective serotonin reuptake inhibitors (64.5% versus 19.3%). The type of initial antidepressant, polypharmacy, psychiatric and medical comorbidities, type of insurance coverage, and type of medical institution visited were associated with short-term use. Short-term use marginally increased the risk of relapse and recurrence of depressive episodes (Hazard ratio: 1.06, 95% confidence intervals 1.048-1.075). CONCLUSIONS: Short-term antidepressant use is widespread in Korea, and assessment in various aspects are necessary to set proper treatment plans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Other studies (1, 3, 19–29, 50–55), however, establish as criteria only factors that are more administrative than clinical, such as the increase in referrals or reinitiation of treatments, which, on the contrary, has the advantage of being purely descriptive but with a risk of underdiagnosing relapses (4).”
From Administrative criteria in the relapse of depressive disorder: a critical appraisal (2026) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370 · cited 1×
“A large number of patients with depression do not return even when their symptoms recur[43].”
BackgroundKessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07495-8 · Cited by 4,492 · cited 1×
“Due to their chronic course and highly recurrent nature, they have significant personal and public health consequences[1].”
BackgroundThe world health report 2001 - Mental health: new understanding, new hope
Sayers, J. G. (2001) · Europe PMC (PubMed Central) · doi:10.1590/s0042-96862001001100014 · Cited by 3,123 · cited 1×
“According to the World Health Organization, depression is predicted to become the second most burdensome disease in 2020 [2].”
MethodSocioeconomic inequalities in depression: a meta-analysis
Lorant, V. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwf182 · Cited by 2,603
The quality of care for depressive and anxiety disorders in the United States
Young, A. S., Klap, R., Sherbourne, C. D., & Wells, K. B. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.1.55 · Cited by 1,061
Risk for recurrence in depression
Burcusa, S. L., & Iacono, W. G. (2007) · Clinical Psychology Review · doi:10.1016/j.cpr.2007.02.005 · Cited by 1,023 · cited 1×
“Most of the variables related to relapses and recurrences in the present study were consistent with previous studies [40].”
ResultRelapse prevention with antidepressant drug treatment in depressive disorders: a systematic review
Geddes, J. R., Carney, S. M., Davies, C., Furukawa, T. A., Kupfer, D. J., Frank, E., & Goodwin, G. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12599-8 · Cited by 945 · cited 1×
“The acute phase treatment should last for at least 6–8 weeks, and should be followed by a continuation phase lasting for 4–9 months beyond the acute phase to consolidate the treatment response and reduce the risk of relapse [4, 5].”
BackgroundAnderson, I. M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00092-0 · Cited by 940
Socioeconomic Status and Mental Illness: Tests of the Social Causation and Selection Hypotheses.
Hudson, C. G. (2005) · American Journal of Orthopsychiatry · doi:10.1037/0002-9432.75.1.3 · Cited by 707
Research works printed but not linked: 1
- SA Bull, 2002, Discontinuing or switching selective serotonin-reuptake inhibitors, Annals of Pharmacotherapy, 36, 578, 10.1345/aph.1A254 · doi:10.1345/aph.1a254 · Paper page
Cited by
Kern, D. M., Cepeda, M. S., DeFalco, F., & Etropolski, M. S. (2020) · BMC Psychiatry · doi:10.1186/s12888-019-2418-7 · Cited by 60
Gutiérrez‐Abejón, E., Herrera‐Gómez, F., Criado-Espegel, P., & Alvarez, E. (2020) · Pharmaceuticals · doi:10.3390/ph13040061 · Cited by 20
“Depression causes severe disabilities in the occupational and social life of patients [1] and it is currently recognized as a global public health concern [2].”
BackgroundCostello, F. J., Kim, C. G., Kang, C. M., & Lee, K. C. (2020) · Healthcare · doi:10.3390/healthcare8040562 · Cited by 9
“Although the maturity hypothesis has been put forward to explain why this age group is at low risk, numbers indicating the use of depressive drugs within this age group suggest a different reality [9,10].”
BackgroundMoon, S. W., Kim, J. W., Kim, D. H., Lee, K. Y., Reines, E. H., Lee, M., & Park, Y. J. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1075939 · Cited by 12
“Furthermore, even when patients receive treatment for MDD, they can remain at risk of relapse (5).”
BackgroundKim, S., & Kim, J. S. (2026) · Journal of Korean Medical Science · doi:10.3346/jkms.2026.41.e43 · Cited by 2
Metadata
- Authors
- Kim, M. J., Kim, N., Shin, D., Rhee, S. J., Park, C. H. K., Kim, H., Cho, S. J., Lee, J. W., Kim, E. Y., Yang, B., & Ahn, Y. M.
- Affiliations
- Seoul National University Hospital (KR)
- Seoul National University (KR)
- Kangbuk Samsung Hospital (KR)
- Eunpyeong Hospital (KR)
- Corresponding author
- Ahn, Yong Min
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2019-09-25
- Volume
- 14
- Issue
- 9
- Pages
- e0222791
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC6760791
- OpenAlex
- W2976540866
- Cited by
- 8
- References
- 47
- Citations by year
- 2026: 3 · 2024: 1 · 2023: 1 · 2020: 3
- FWCI
- 0.46
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Keywords
- depression, depression relapse, depression recurrence, antidepressant prescribing, tricyclic antidepressants, selective serotonin reuptake inhibitors, polypharmacy, comorbidities, insurance coverage, South Korea
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Antidepressive Agents, Depression, Drug Utilization, Female, Humans, Male, Middle Aged, Drug Prescriptions, Recurrence, Retrospective Studies, Time Factors, Comorbidity, Treatment Outcome, Pharmacoepidemiology, Polypharmacy, Young Adult, Republic of Korea
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The epidemiology of antidepressant use in South Korea: does short-term antidepressant use affect the relapse and recurrence of depressive episodes. https://app.cochat.ai/papers/10.1371/journal.pone.0222791
- The paper
- Kim, M. J., Kim, N., Shin, D., Rhee, S. J., Park, C. H. K., Kim, H., Cho, S. J., Lee, J. W., Kim, E. Y., Yang, B., & Ahn, Y. M. (2019). The epidemiology of antidepressant use in South Korea: does short-term antidepressant use affect the relapse and recurrence of depressive episodes. PLOS ONE. https://doi.org/10.1371/journal.pone.0222791
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.